Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.
Department of Radiological Sciences, UCLA, Los Angeles, California, USA.|Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.|Department of Biomedical Physics, UCLA, Los Angeles, California, USA.
J Paul
JP
Finn
Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Kim-Lien
KL
Nguyen
Department of Radiological Sciences, UCLA, Los Angeles, California, USA.|Department of Biomedical Physics, UCLA, Los Angeles, California, USA.
Peng
P
Hu
D003287:Contrast Media; D052203:Ferrosoferric Oxide; D005682:Gadolinium; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008279:Magnetic Resonance Imaging; D012306:Risk
D003287:Contrast Media; D005682:Gadolinium; D052203:Ferrosoferric Oxide